BRD

Zuprevo from Merck

Merck Animal Health announces the US approval of ZUPREVOTM (tildipirosin) – a novel, new macrolide antibiotic for the management of bovine respiratory disease (BRD). ZUPREVO is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus… Continue reading →

Copyright © 2013. All Rights Reserved.